Imricor Medical Systems, Inc. (ASX: IMR) Announces Strong Q4 Results
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Forbidden Foods Limited (ASX:FFF) reports significant revenue growth and operational achievements for Q2 FY25.
Nova Minerals Limited reports high-grade gold and gallium findings at its Wombat prospect, indicating growing potential in its Estelle Project.
Core Lithium Ltd (ASX: CXO) reports on its December quarterly activities, highlighting significant cash reserves, exploration success, and director appointment.
Orpheus Uranium Limited reports cash flow details for the December 2024 quarter, indicating a solid cash position for ongoing operations.
Mithril Silver and Gold Limited announces significant drilling results with impressive grades at the Copalquin District project.
Netwealth Group Limited (ASX: NWL) reports record net inflows and strong growth in FUA for the December 2024 quarter.
Praemium Limited (ASX:PPS) reports a 29% increase in FUA to $62.1 billion, highlighting strong growth metrics and inflows for Q2 FY2025.
Firebrick Pharma Ltd reports significant operational and financial updates, marking progress in Singapore sales of Nasodine during the December quarter.
Ampol Limited (ASX:ALD) provides a fourth quarter update on refiner margins and trading conditions, projecting significant profit for the year.